Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Source: NASDAQ Stocks / 21 Jun 2024 09:55:23 America/Chicago
Gilead Sciences, Inc. GILD announced upbeat top-line results from an interim analysis of its late-stage study PURPOSE 1.
https://www.nasdaq.com/articles/gilead-gild-twice-yearly-hiv-shot-prevents-infection